FMNL2
Basic information
Region (hg38): 2:152335174-152649826
Previous symbols: [ "FHOD2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FMNL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 1 | |||||
Total | 0 | 0 | 32 | 4 | 2 |
Variants in FMNL2
This is a list of pathogenic ClinVar variants found in the FMNL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-152335646-A-G | not specified | Uncertain significance (May 12, 2024) | ||
2-152521945-T-C | Benign (Mar 22, 2022) | |||
2-152549034-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
2-152549066-C-G | Likely benign (Aug 08, 2018) | |||
2-152558730-T-TGTTTTTTTTTC | Likely benign (Jan 12, 2024) | |||
2-152558787-T-C | Crohn disease | Likely pathogenic (Feb 20, 2021) | ||
2-152558819-G-T | not specified | Uncertain significance (Apr 08, 2022) | ||
2-152560945-G-T | not specified | Uncertain significance (Jun 24, 2022) | ||
2-152561011-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
2-152561043-C-G | Likely benign (Jul 06, 2018) | |||
2-152575215-A-G | FMNL2-related disorder | Uncertain significance (May 31, 2024) | ||
2-152578956-G-T | not specified | Uncertain significance (Nov 30, 2022) | ||
2-152580961-A-C | not specified | Uncertain significance (Feb 28, 2023) | ||
2-152580964-C-G | FMNL2-related disorder | Uncertain significance (Jul 24, 2023) | ||
2-152580990-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
2-152607357-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
2-152607358-G-A | FMNL2-related disorder • not specified | Uncertain significance (Jun 25, 2023) | ||
2-152611598-A-G | Benign (Jul 19, 2018) | |||
2-152617138-T-G | not specified | Uncertain significance (Jun 02, 2023) | ||
2-152618997-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
2-152619005-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
2-152619033-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
2-152619045-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
2-152619149-C-T | Likely benign (Jul 02, 2018) | |||
2-152619514-A-G | not specified | Uncertain significance (Dec 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FMNL2 | protein_coding | protein_coding | ENST00000288670 | 26 | 314598 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.993 | 0.00680 | 124731 | 0 | 13 | 124744 | 0.0000521 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.86 | 375 | 566 | 0.662 | 0.0000292 | 7135 |
Missense in Polyphen | 38 | 84.406 | 0.45021 | 1112 | ||
Synonymous | 1.71 | 179 | 210 | 0.850 | 0.0000110 | 2032 |
Loss of Function | 5.72 | 9 | 54.6 | 0.165 | 0.00000277 | 719 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000943 | 0.0000938 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000566 | 0.0000556 |
Finnish | 0.0000929 | 0.0000928 |
European (Non-Finnish) | 0.0000457 | 0.0000442 |
Middle Eastern | 0.0000566 | 0.0000556 |
South Asian | 0.0000660 | 0.0000654 |
Other | 0.000167 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics. {ECO:0000269|PubMed:21834987}.;
- Pathway
- miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;EMT transition in Colorectal Cancer;Signal Transduction;RHO GTPases Activate Formins;RHO GTPase Effectors;Signaling by Rho GTPases
(Consensus)
Intolerance Scores
- loftool
- 0.156
- rvis_EVS
- 0.14
- rvis_percentile_EVS
- 63.62
Haploinsufficiency Scores
- pHI
- 0.374
- hipred
- Y
- hipred_score
- 0.682
- ghis
- 0.534
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.874
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fmnl2
- Phenotype
Gene ontology
- Biological process
- cytoskeleton organization;regulation of cell morphogenesis;cortical actin cytoskeleton organization
- Cellular component
- cytosol
- Molecular function
- actin binding;Rho GTPase binding;cadherin binding